Norson Biotechnology Funding, Investors & Competitors

Norson Biotechnology has raised $133M across 2 funding rounds, most recently a $71M Series B in June 2020.

Last Norson Biotechnology funding round

$71M

Series B · Jun 2020

Cumulative funding Norson Biotechnology raised

$133M

across 2 funding rounds

Key investors in Norson Biotechnology

Norson Biotechnology Overview

About Norson Biotechnology

Norson Biotechnology is a Chinese firm producing probiotic health products. It manufactures edible probiotic powders, solid beverages, and fermented lactic acid bacteria drinks for digestive and immune support. The portfolio targets consumer wellness through functional foods distributed in Asia.


Founded

2018

HQ

ChinaQingdao

Status

Privately held

Customer focus

B2B

Revenue model

Product sales

Norson Biotechnology Funding History

Norson Biotechnology has raised a total of $133M across 2 funding rounds.

Norson Biotechnology's first fundraising round was a $62M Series A in January 2018. The most recent completed round was a $71M Series B in June 2020.

Norson Biotechnology funding rounds

Norson Biotechnology funding rounds
DateStageInvestorsRaised
Jun 2020Series BDT Capital Partners (lead); Sunshine Insurance Group; Yuanchuang Investment Management; Qiandao Fund; Zhuhai Huajin Capital Co; Yantai Financial Investment Holding; OrbiMed; Horus Capital; Ligong investment; China Merchants Securities; Xinzhen Tianying Fund$71M
Jan 2018Series A-$62M

Who has invested in Norson Biotechnology?

11 investors have backed Norson Biotechnology across its funding rounds, including OrbiMed, DT Capital Partners, Horus Capital, Zhuhai Huajin Capital Co, China Merchants Securities and Sunshine Insurance Group.

Lead investors include DT Capital Partners.


Norson Biotechnology Investors

Investors in Norson Biotechnology by funding rounds participated
InvestorHQRoundsRoleFirst check
Sunshine Insurance GroupChinaBeijing1ParticipantJun 2020
Yuanchuang Investment ManagementChinaQingdao1ParticipantJun 2020
Qiandao FundChinaBeijing1ParticipantJun 2020
DT Capital PartnersChinaChina1LeadJun 2020
Zhuhai Huajin Capital CoChinaZhuhai1ParticipantJun 2020
Yantai Financial Investment Holding--1ParticipantJun 2020
OrbiMedUnited StatesNew York City, NY1ParticipantJun 2020
Horus CapitalChinaQingdao1ParticipantJun 2020
Ligong investmentChinaShanghai1ParticipantJun 2020

This data is available for Pro users. Sign up to see all 11 Norson Biotechnology investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Norson Biotechnology Competitors

Norson Biotechnology competitors include listed companies like Divi's Laboratories, Yunnan Baiyao Group, Zhejiang NHU and Hebei Yangyuan Zhihui, and private ones like Impossible Foods and L&P Cosmetic.

Public and private companies comparable to Norson Biotechnology
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Divi's LaboratoriesIndiaIndiaPublicly listed$1.1B$374M$26B21.2x
Yunnan Baiyao GroupChinaChinaPublicly listed$6.1B$945M$14B1.9x
Zhejiang NHUChinaChinaPublicly listed$3.3B$1.5B$12B3.1x
Hebei Yangyuan ZhihuiChinaChinaPublicly listed$796M$254M$8.1B8.4x
Impossible FoodsUnited StatesSan Francisco, CAPrivate$460M-$7B15.2x
L&P CosmeticSouth KoreaSeoulPrivate--$1.1B-

Norson Biotechnology Public Comps

Norson Biotechnology is still privately-owned, but its public comps include Coca-Cola, Nestlé, PepsiCo, AB InBev, Unilever, Monster Beverage, Mondelez, Nongfu Spring, Hindustan Unilever and Coca-Cola Europacific Partners.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Coca-Cola$48B$18B8.5x8.3x22.8x24.1x
Nestlé$109B$19B2.9x2.8x16.2x14.4x
PepsiCo$94B$16B2.4x2.3x14.5x11.8x
AB InBev$59B$20B3.9x3.6x11.7x10.0x
Unilever$58B$12B2.9x2.8x13.6x12.4x
Monster Beverage$8.3B$2.5B10.1x9.0x33.3x28.9x
Mondelez$39B$4.7B2.6x2.5x21.4x14.9x
Nongfu Spring$7.8B$3.5B6.9x6.3x15.2x14.0x

This data is available for Pro users. Sign up to see all Norson Biotechnology competitors and their valuation data.

Start Free Trial

Common questions about Norson Biotechnology

When was Norson Biotechnology founded?Norson Biotechnology was founded in 2018.
Where is Norson Biotechnology headquartered?Norson Biotechnology is headquartered in Qingdao, China.
Is Norson Biotechnology publicly listed?No, Norson Biotechnology is a private, VC-backed company.
How much funding has Norson Biotechnology raised?Norson Biotechnology has raised $133M across 2 funding rounds.
What was Norson Biotechnology's last funding round?Norson Biotechnology's last funding round was a $71M Series B in June 2020, led by DT Capital Partners.
Who are Norson Biotechnology's investors?Norson Biotechnology's investors include Sunshine Insurance Group, Yuanchuang Investment Management, Qiandao Fund, DT Capital Partners, Zhuhai Huajin Capital Co, Yantai Financial Investment Holding, OrbiMed, Horus Capital, Ligong investment, China Merchants Securities and 1 other.
Which companies are comparable to Norson Biotechnology?Companies comparable to Norson Biotechnology include Divi's Laboratories, Yunnan Baiyao Group, Zhejiang NHU, Hebei Yangyuan Zhihui, Impossible Foods and L&P Cosmetic.

See companies similar to Norson Biotechnology

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial